Browse Category

NYSE:RCUS News 8 January 2026

Arcus Biosciences (NYSE:RCUS) stock slides on Morgan Stanley downgrade as casdatifan 2026 timeline sharpens

Arcus Biosciences (NYSE:RCUS) stock slides on Morgan Stanley downgrade as casdatifan 2026 timeline sharpens

Arcus Biosciences shares dropped 9.3% to $21.05 Thursday after Morgan Stanley downgraded the stock and cut its price target to $20. The company highlighted a February data update and a Jan. 14 J.P. Morgan conference slot. BlackRock disclosed a 10.4% stake as of Dec. 31. President Juan C. Jaen reported selling 31,823 shares on Jan. 5 under a pre-set trading plan.

Stock Market Today

Real estate stocks rise as rate-cut bets return; XLRE ends at $41.99 ahead of payrolls and CPI

Real estate stocks rise as rate-cut bets return; XLRE ends at $41.99 ahead of payrolls and CPI

7 February 2026
U.S. real estate stocks rose Friday, with XLRE up 1.8% to $41.99 and VNQ and IYR each gaining 1.6%. The Dow closed above 50,000 for the first time as the 10-year Treasury yield ended at 4.206%. Bank of America downgraded Public Storage and Extra Space Storage, citing weak housing turnover and high borrowing costs. The delayed January jobs report is set for Feb. 11, with CPI due Feb. 13.
Go toTop